ACE and pneumoconiosis: Rise of serum ACE activity has been found in 93 % of patients with active sarcoidosis, 41 % of patients with TB and 56 % of patients with nonspecific inflammatory lung diseases including fibrosing alveolitis, histiocytosis X, and pneumoconiosis [23].